Implicit Bias in the Evidence: An Evaluation of Female-Predominant Disease
Implicit Bias in the Evidence: An Evaluation of Female-Predominant Disease
批准号:
10686886
负责人:
Julia F Simard
金额:
$53.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-22 至 2024-08-31
关键词:
AddressAgeAnxietyAutoimmune DiseasesAwarenessBehavioral SciencesBlindedCaringCase StudyClinicalClinical ManagementCognitiveColon CarcinomaComplexDecision MakingDiagnosisDiagnosticDiagnostic ErrorsDiagnostic testsDifferential DiagnosisDiscriminationDiseaseDisparityEvaluationEvidence Based MedicineEvidence based practiceExperimental DesignsFatigueFemaleFocus GroupsGenderGoalsGoutHeterogeneityInternetInterventionLeftLupusMeasuresMedical ErrorsMedicineMental DepressionMethodologyMethodsMinorityModelingMorphologic artifactsMultiple SclerosisNatureOsteoporosisOutcomePainPatientsPatternPhysiciansPopulationPrimary CareProbabilityProviderRaceRandomizedReaction TimeRecording of previous eventsResearchRiskRoleSeriesSerologySex BiasSideSigns and SymptomsSociologySpecialistStandardizationStrategic PlanningSurveysTimeTrainingUnited States National Institutes of HealthWomanWomen&aposs HealthWorkblack womenclinical decision-makingclinical practiceclinical trainingcostdesigndiagnostic criteriadiagnostic strategydisease heterogeneityevidence baseexperienceexperimental studygender disparityhealth disparityheuristicsimplicit biasimprovedindividual patientinnovationmalemedical specialtiesmennovelpatient subsetsracial disparityrheumatologistselective attentionsexsex disparitysocialuser centered design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This research explores the use of heuristics in diagnostic decision making for conditions that do not have
definitive diagnostic tests and rely on a set of diagnostic criteria. Because clinicians are Bayesian by nature,
cognitive heuristics are used to estimate the probability of a given condition based on the representativeness of
that case among “the average” in diagnostic decision making. Over time, reliance on these shortcuts influences
how patients are diagnosed, and in turn, these patients add to the growing evidence base. This may lead to a
multi-state confirmation bias in the practice of evidence-based medicine. Our first step to evaluate this complex
cycle is to question how the evidence and deviations from the norm influence what diagnosis a clinician gives.
We ask: Does the diagnosis a patient receives vary when all that differs is their sex, gender, or race? Our initial
pilot shows that clinicians make more diagnostic errors when presented with patients of sex/gender/race that is
less common, despite identical clinical signs and symptoms of lupus. We will extend on our experimental
approach evaluating implicit bias in the diagnosis of lupus, which builds off of research on discrimination in
hiring. This work specifically asks whether when the disease presents the same, does a patient deviating from
the “norm” based on the evidence, influence the diagnosis? We will consider additional female-predominant
diseases and determine whether a physician's diagnosis is influenced by a patient's sex/gender/race holding
everything else constant. First, we will conduct a national internet-based randomized experiment among
specialists to assess the role of sex/gender/race in the clinical workup and its contribution to observed
heterogeneity and disparities. Second, we will conduct additional randomized experiments in primary care to
determine how sex/gender/race influences their clinical workup and referral patterns. Third, we will use mixed
methods to characterize and improve our understanding of how clinicians approach diagnostic questions, and
identify non-biological, potentially modifiable factors contributing to health disparities. We will conduct focus
groups with providers using experimental results as discussion prompts to contextualize findings and inform
strategies to address this type of multi-state confirmation bias. This innovative work adapts a novel method by
combining methods from sociology, experimental design, and behavioral science. Our findings will increase
clinicians' awareness of how cognitive biases that may lead to medical errors, and will demonstrate how an
incomplete evidence base may propagate health disparities leading to delayed diagnosis, worsening disease,
and irreversible damage.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
-
批准号:10417134
-
项目类别:
-
资助金额:$53.5万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
Implicit Bias in the Evidence: An Evaluation of Female-Predominant Disease
-
批准号:10468199
-
项目类别:
-
资助金额:$53.18万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
-
批准号:10220856
-
项目类别:
-
资助金额:$53.12万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
-
批准号:10659214
-
项目类别:
-
资助金额:$46.9万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
Implicit Bias in the Evidence: An Evaluation of Female-Predominant Disease
-
批准号:10062770
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
Implicit Bias in the Evidence: An Evaluation of Female-Predominant Disease
-
批准号:10268253
-
项目类别:
-
资助金额:$54.16万
-
财政年份:2020
-
负责人:Julia F Simard
-
依托单位:
A Population-based Study of SLE Pregnancy: Risks and Outcomes in Mother and Child
-
批准号:8930446
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2014
-
负责人:Julia F Simard
-
依托单位:
A Population-based Study of SLE Pregnancy: Risks and Outcomes in Mother and Child
-
批准号:8768182
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2014
-
负责人:Julia F Simard
-
依托单位:
A Population-based Study of SLE Pregnancy: Risks and Outcomes in Mother and Child
-
批准号:9102738
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2014
-
负责人:Julia F Simard
-
依托单位:
A Population-based Study of SLE Pregnancy: Risks and Outcomes in Mother and Child
-
批准号:9314989
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2014
-
负责人:Julia F Simard
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: